💰 Financial Record
paymentTransaction Details
Amount
USD
$255,000,000.0
Payer (From)
Undisclosed Partner
Linked to Undisclosed Partner
Payee (To)
Amyris
Linked to Amyris
Transaction Date
February 01, 2019
Description
Partnership agreement for cannabinoid development valued at up to $255MM, including upfront payment and milestone payments (excluding royalties).
Additional Details
Date string:
February 2019
Amount string:
255000000
Source document:
HOUSE_OVERSIGHT_024836.jpg
📄 Source Document
HOUSE_OVERSIGHT_024836.jpg
ESTATE Collection
Document Summary
This document is page 20 of a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. It details the scientific process of biosynthetic cannabinoid production via fermentation and highlights a specific February 2019 business deal where Amyris signed a partnership valued at up to $255 million with an 'undisclosed partner.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein financial record